DINESH

Poly Medicure

Latest CMP 1,674
Today's Change ▲ 1.77%
52-Week High / Low 2,059 | 1,189
Price Date: 30-Sep-2026
Recommendation Buy
Target Price 2,606
Expected Upside 24.8%
Forecast Horizon 2 Years
Historical CAGR 22.9%
1,000 Invested 01-Oct-2006
Today's Value 61,784
Investment Period 20 Years

Stock Snapshot

Post Results Return
+3.1%
Mild Positive Re-rating
1-Year Target Price
2,276
2-Year Target Price
2,606
52-Week High / Low
2,059 / 1,189
20-Day Return
-5.4%
Market Cap (Cr.)
16,966
Current PE
52.6
P/BV Ratio
5.5
Dividend Yield
0.2%
Industry PE
40.0

Price Performance

Vista Outlook

Basis of our Recommendation

Poly Medicure is strategically transitioning to 'PolyMed 3.0', focusing on high-complexity, high-margin medical device segments such as cardiology and orthopedics, which are expected to drive revenue growth. Management's confidence in doubling revenue by FY30 is supported by a robust pipeline of new product launches and deeper penetration into the Indian hospital sector. However, the company faces near-term challenges, including geopolitical disruptions and regulatory delays affecting integration of European acquisitions, which may pressure margins. Vista's financial outlook anticipates stable revenue growth aligned with historical performance, although margins are expected to remain under pressure due to high capex and integration costs. The favorable industry dynamics, including improving pricing power and a growing biopharma market, provide a supportive backdrop for Poly Medicure's expansion. Over the next 12-24 months, key opportunities include leveraging import substitution and expanding international sales, while watchpoints include successful integration of acquisitions and managing raw material price volatility

👍 Why We Like This Stock

  • Management's focus on high-margin segments is expected to drive significant revenue growth
  • A strong pipeline of new product launches and deeper market penetration in India supports long-term expansion
  • Improving pricing power in the industry enhances profitability potential

⚠ Things To Watch Out For

  • Short-term margin pressures due to high capex and integration costs from recent acquisitions
  • Geopolitical disruptions and regulatory delays may hinder operational efficiency
  • Raw material price volatility poses risks to production capabilities and margins

Key Parameters

Balance Sheet Strength
Conservatively Financed
Market Share
Stable
Industry Outlook
Improving
Analyst View
Not Available
Dividend History
Consistent
FII Holdings
Stable

Financial Snapshot

View Technicals Analysis →
Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 1,375 1,669 1,875 2,054 2,374
Profit Before Tax (Cr.) 345 447 534 534 632
PBT Margin 25.1% 26.8% 28.5% 26.0% 26.6%
Net Profit (Cr.) 267 352 332 406 481
Earnings Per Share 26.4 34.8 32.8 40.1 47.5

Analyst Recommendations

No analyst recommendations available.

Consensus Recommendation ► None
Consensus Target —
Coverage 0 Analysts
Analysts' Viewpoint

Company Overview

Show Company Profile

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.